FDA Approves Litfulo for Teens, Adults With Alopecia Areata

TUESDAY, June 27, 2023 -- The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to...